Home/Hallux/Seth M. Birnbaum

SM

Seth M. Birnbaum

Board Member

Therapeutic Areas

Dermatology Infectious Disease

Hallux Pipeline

Drug	Indication	Phase
Hallux Subungual Gel (HSG)	Onychomycosis (fungal nail infection)	Phase 2a

Leadership Team at Hallux

Co-Founder, CEO, Board Member

Jay E. Birnbaum, PhD

Co-Founder, Board Member

William P. Forbes, PharmD

Board Member & Consultant (Product Development & CMC)

View full Hallux profile